Inotiv, Inc. (NOTV) can hold. Click on Rating Page for detail.
The price of Inotiv, Inc. (NOTV) is 4.27 and it was updated on 2024-05-05 07:00:44.
Currently Inotiv, Inc. (NOTV) is in undervalued.
News |
---|
Why Fast-paced Mover Inotiv (NOTV) Is a Great Choice for Value Investors
|
Is Inotiv (NOTV) a Great Value Stock Right Now?
|
Here's Why Momentum in Inotiv, Inc. (NOTV) Should Keep going
|
Rocket Stocks: 3 Picks That Could Skyrocket Your Portfolio by 2025
|
3 Stocks That Could Fast-Track Your Millionaire Status
|
News |
---|
Inotiv, Inc. (NOTV) is a Great Momentum Stock: Should You Buy?
|
Despite Fast-paced Momentum, Inotiv, Inc. (NOTV) Is Still a Bargain Stock
|
Should Value Investors Buy Inotiv (NOTV) Stock?
|
3 Overlooked Stocks with Potential for 500% Growth by 2025
|
Millionaire-Makers: 3 Game-Changing Stocks Ready for Historic Gains
|
Inotiv, Inc. (NOTV) Is Attractively Priced Despite Fast-paced Momentum
|
Are Investors Undervaluing Inotiv (NOTV) Right Now?
|
Inotiv, Inc. (NOTV) Reports Q1 Loss, Lags Revenue Estimates
|
Inotiv, Inc. to Report Fiscal 2024 First Quarter Financial Results and Host Conference Call on Wednesday, February 7, 2024
|
Inotiv: The Business Is Recovering, The Stock Will Follow
|
Inotiv, Inc. (NOTV) Shows Fast-paced Momentum But Is Still a Bargain Stock
|
Inotiv, Inc. (NOTV) Q4 2023 Earnings Call Transcript
|
Inotiv, Inc. to Report Fiscal 2023 Fourth Quarter and Full Year Results and Host Conference Call on Monday, December 11, 2023
|
Inotiv Provides Business Updates and Upcoming Investor Conferences Update
|
Inotiv, Inc. to Participate in Upcoming Investor Conferences
|
Inotiv, Inc. to Participate in Upcoming September 2023 Investor Conferences
|
Inotiv, Inc. (NOTV) Q3 2023 Earnings Call Transcript
|
Inotiv, Inc. (NOTV) Q3 Earnings Miss Estimates
|
Inotiv, Inc. to Report Fiscal 2023 Third Quarter Financial Results and Host Conference Call on Thursday, August 10, 2023
|
Strength Seen in Inotiv, Inc. (NOTV): Can Its 34.5% Jump Turn into More Strength?
|
Does Inotiv, Inc. (NOTV) Have the Potential to Rally 185.14% as Wall Street Analysts Expect?
|
5 High Earnings Yield Gems for Successful Value Investing
|
Here Is Why Bargain Hunters Would Love Fast-paced Mover Inotiv, Inc. (NOTV)
|
Inotiv, Inc. to Present at Jefferies 2023 Healthcare Conference
|
Inotiv, Inc. to Participate in May Investor Conferences
|
Wall Street Analysts Predict a 168.98% Upside in Inotiv, Inc. (NOTV): Here's What You Should Know
|
Inotiv, Inc. (NOTV) Q2 2023 Earnings Call Transcript
|
Inotiv, Inc. to Report Fiscal 2023 Second Quarter Financial Results and Host Conference Call on Thursday, May 11, 2023
|
Inotiv, Inc. (NOTV) Q1 2023 Earnings Call Transcript
|
Inotiv, Inc. to Report Fiscal 2023 First Quarter Financial Results and Host Conference Call on Monday, February 13, 2023
|
Inotiv: Turning Focus To Organic Growth
|
Inotiv: High Expenses Likely To Impair Long-Term Profitability
|
Inotiv, Inc. (NOTV) Q4 2022 Results - Earnings Call Transcript
|
Inotiv, Inc. to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results and Host Conference Call on Tuesday, January 10, 2023
|
Inotiv, Inc. to Report Fourth Quarter Fiscal 2022 Financial Results and Host Conference Call on Monday, December 12, 2022
|
Inotiv, Inc. to Participate in November Investor Conferences
|
Inotiv, Inc. to Participate in September Investor Conferences
|
Inotiv, Inc. (NOTV) CEO Bob Leasure on Q3 2022 Results - Earnings Call Transcript
|
Inotiv, Inc. to Report Third Quarter Fiscal 2022 Financial Results and Host Conference Call on Wednesday, August 10, 2022
|
Inotiv, Inc. to Participate in Upcoming Investor Conferences
|
Inotiv, Inc. (NOTV) CEO Bob Leasure on Q2 2022 Results - Earnings Call Transcript
|
Inotiv, Inc. to Report Second Quarter Fiscal 2022 Financial Results and Host Conference Call on Thursday, May 12, 2022
|
5 Stocks Insiders Are Charging Up for Spring
|
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
|
Inotiv, Inc. (NOTV) CEO Bob Leasure on Q1 2022 Results Earnings Call Transcript
|
Inotiv: Leading Mid-Market CRO Ups Its Game
|
Inotiv, Inc. (NOTV) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
|
Inotiv, Inc. (NOTV) CEO Bob Leasure on Q4 2021 Results - Earnings Call Transcript
|
Inotiv: Q4 Earnings Insights
|
A Preview Of Inotiv's Earnings
|
Inotiv, Inc. Reschedules Fourth Quarter Fiscal 2021 Financial Results and Conference Call for Thursday, December 16, 2021
|
Inotiv Stock (NOTV): Why The Price Surged Today
|
Bears are Losing Control Over Inotiv, Inc. (NOTV), Here's Why It's a 'Buy' Now
|
Inotiv Earnings Preview
|
Inotiv, Inc. to Report Fourth Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, December 7, 2021
|
Inotiv, Inc. to Participate in Upcoming Investor Conferences
|
NOTV Stock: Why It Increased This Week
|
Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.
|
Inotiv, Inc. Announces Closing of $125 Million Convertible Senior Notes Offering and Full Exercise of Option to Purchase Additional $15 Million of Notes
|
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Inotiv, Inc. - NOTV
|
Inotiv Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Inotiv, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – NOTV
|
Inotiv, Inc. Prices Upsized $125 Million Convertible Senior Notes Offering
|
Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering
|
Inotiv Scoops Up Envigo For $200M To Enhance Research, Drug Discovery Solutions
|
NOTV Stock: Why It Significantly Increased Today
|
Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
|
Inotiv, Inc. to Participate in the 2021 Colliers Institutional Investor Conference
|
Inotiv: Q3 Earnings Insights
|
Inotiv, Inc.'s (NOTV) CEO Robert Leasure on Q3 2021 Results - Earnings Call Transcript
|
Inotiv, Inc. Announces Acquisition of Gateway Pharmacology Laboratories
|
Inotiv Acquires Laboratory Instrumentation for Discovery and Development of Novel Therapies
|
Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma's BioReliance® portfolio
|
Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology and Hires Nicolette Jackson to Lead Effort
|
Inotiv Set to Join Russell 3000® Index and Russell 2000® Index
|
Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity
|
Inotiv, Inc. (NOTV) CEO Robert Leasure on Q2 2021 Results - Earnings Call Transcript
|
Inotiv, Inc. Announces Second Quarter Fiscal 2021 Financial Results
|
Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.
|
Inotiv, Inc. to Report Second Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, May 5, 2021
|
Inotiv, Inc. Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
|
NOTV Stock: Over 15% Decrease Pre-Market Explanation
|
Inotiv, Inc. Announces Pricing of Public Offering of 2,647,059 Common Shares
|
Inotiv, Inc. Announces Proposed Public Offering of Common Shares
|
Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for Second Quarter and Year to Date Fiscal 2021
|
Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.
|
Inotiv, Inc. Enhances Histopathology Offering with Announcement of Agreement to Purchase HistoTox Labs, Inc.
|